SCHEMBL9516252

SCHEMBL9516252

O=C(NS(=O)(=O)c1ccc(Oc2cccc(C(F)(F)F)c2)cc1)c1ccc(CO)nc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 8/20 0.50
▸ MCL1 Q07820 8/20 0.50
▸ MMP2 P08253 1/20 0.47
▸ MMP3 P08254 1/20 0.47
▸ MMP9 P14780 1/20 0.47
▸ MMP8 P22894 1/20 0.47
▸ MMP13 P45452 1/20 0.47
▸ MMP14 P50281 1/20 0.47
▸ MAPK14 Q16539 1/20 0.45
▸ P4HTM Q9NXG6 2/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ NR3C1 P04150 1/20 0.42
▸ PGR P06401 1/20 0.42
▸ AR P10275 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ EGFR P00533 1/20 0.42
▸ NAMPT P43490 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517224 0.90 BCL2L1 (0.49) BCL2L1MCL1MMP2MMP3MMP9
SCHEMBL9516149 0.87 MCL1 (0.53) BCL2L1MCL1MMP13P4HTMEGFR
SCHEMBL9519730 0.86 MCL1 (0.62) BCL2L1MCL1MMP2MMP13MMP14
SCHEMBL8868123 0.85 BCL2L1 (0.49) BCL2L1MCL1MMP2MMP3MMP9
SCHEMBL9519096 0.83 BCL2L1 (0.53) BCL2L1MCL1P4HTMPGREGFR
SCHEMBL9143139 0.83 P4HTM (0.48) BCL2L1MCL1MMP2MMP3MMP9
SCHEMBL9516981 0.83 BCL2L1 (0.60) BCL2L1MCL1MMP2MMP9MMP13
SCHEMBL7870464 0.83 BCL2L1 (0.45) BCL2L1MCL1MMP2MMP3MMP9
SCHEMBL9018320 0.83 RAB9A (0.49) BCL2L1MCL1MMP2MMP3MMP9
SCHEMBL8868192 0.82 P4HTM (0.49) BCL2L1MCL1MMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 — — EP disclosed
Send feedback